Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells

Growth Factor ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Anticancer Effects ◽

Epidermal Growth ◽

Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-2128 ◽

2006 ◽

Vol 12 (3) ◽

pp. 1013s-1018s ◽

Cited By ~ 42

Author(s):

Hyun-Jung Kim ◽

Xiaojiang Cui ◽

Susan G. Hilsenbeck ◽

Adrian V. Lee

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progesterone Receptor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Comparing protein and mRNA expressions of the human epidermal growth factor receptor family in estrogen receptor-positive breast cancer

Medical Molecular Morphology ◽

10.1007/s00795-018-0206-y ◽

2018 ◽

Vol 52 (2) ◽

pp. 90-98 ◽

Cited By ~ 2

Author(s):

Sasagu Kurozumi ◽

Yuri Yamaguchi ◽

Hiroshi Matsumoto ◽

Kenichi Inoue ◽

Masafumi Kurosumi ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Family ◽

Modulation of Epidermal Growth Factor Receptor in Endocrine-Resistant, Estrogen-Receptor-Positive Breast Cancer

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.2002.tb04101.x ◽

2006 ◽

Vol 963 (1) ◽

pp. 104-115 ◽

Cited By ~ 45

Author(s):

R. I. NICHOLSON ◽

I. R. HUTCHESON ◽

M. E. HARPER ◽

J. M. KNOWLDEN ◽

D. BARROW ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Multitargeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2???Positive Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000182412.83562.76 ◽

2005 ◽

Vol 28 (6) ◽

pp. 631-633 ◽

Cited By ~ 3

Author(s):

Zeina A. Nahleh ◽

Abdul-Rahman Jazieh

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)

10.1158/1538-7445.sabcs18-ot1-03-01 ◽

2019 ◽

Author(s):

G Curigliano ◽

S Cresta ◽

Y-S Yap ◽

D Juric ◽

FP Duhoux ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Breast Cancer ◽

Phase 1 ◽

Growth Factor Receptor ◽

Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer

10.1158/1538-7445.sabcs19-pd7-07 ◽

2020 ◽

Author(s):

Virginia Kaklamani ◽

Aditya Bardia ◽

Sharon Wilks ◽

Amy Weise ◽

Donald Richards ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Phase 1 ◽

Growth Factor Receptor ◽

Final Analysis ◽

Phase 1 Study ◽

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Cancer Science ◽

10.1111/cas.12897 ◽

2016 ◽

Vol 107 (4) ◽

pp. 491-498 ◽

Cited By ~ 19

Author(s):

Mai Tomiguchi ◽

Yutaka Yamamoto ◽

Mutsuko Yamamoto‐Ibusuki ◽

Lisa Goto‐Yamaguchi ◽

Yoshitaka Fujiki ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor

Molecular and Clinical Oncology ◽

10.3892/mco.2016.776 ◽

2016 ◽

Vol 4 (4) ◽

pp. 648-654 ◽

Cited By ~ 11

Author(s):

MASAHIRO OHARA ◽

KAZUO MATSUURA ◽

ETSUSHI AKIMOTO ◽

MIDORI NOMA ◽

MIHOKO DOI ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Ki67 Labeling Index ◽

Human Epidermal Growth Factor Receptor 2 Status Modulates Subcellular Localization of and Interaction with Estrogen Receptor α in Breast Cancer Cells

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-0740-3 ◽

2004 ◽

Vol 10 (11) ◽

pp. 3621-3628 ◽

Cited By ~ 65

Author(s):

Zhibo Yang ◽

Christopher J. Barnes ◽

Rakesh Kumar

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Estrogen Receptor Α ◽

Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3107-6 ◽

2016 ◽

Vol 78 (4) ◽

pp. 685-695 ◽

Cited By ~ 4

Author(s):

Ji Hyun Park ◽

Myung Joo Kang ◽

Jin-Hee Ahn ◽

Jeong Eun Kim ◽

Kyung Hae Jung ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Growth Factor Receptor ◽

Her2 Positive ◽

Epidermal Growth ◽